Michael Bassett, a long-time lobbyist and former Capitol Hill staffer, has been named senior vice president of government relations for the American Health Care Association/National Center for ...
ASN-90 is under clinical development by Asceneuron and currently in Phase I for Parkinson’s Disease. According to GlobalData, Phase I drugs for Parkinson’s Disease have a 72% phase transition success ...